Hiba El Hajj

Title: Hiba El Hajj: Innovator in Acute Myeloid Leukemia Treatment

Introduction

Hiba El Hajj is a prominent inventor based in Beirut, Lebanon. She has made significant contributions to the field of medicine, particularly in the treatment of acute myeloid leukemia (AML). Her innovative approach combines arsenic compounds with retinoids, showcasing her dedication to advancing cancer treatment.

Latest Patents

Hiba El Hajj holds a patent for a groundbreaking invention titled "Combination of an arsenic compound and at least one retinoid for treating acute myeloid leukemia." This patent outlines methods and pharmaceutical compositions aimed at treating NPM-1-driven AML. The invention involves administering a therapeutically effective amount of both an arsenic compound and a retinoid to patients in need of treatment.

Career Highlights

Throughout her career, Hiba has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Diderot-Paris 7. Her work in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her research and contributions to medical science.

Collaborations

Hiba has had the opportunity to work alongside notable colleagues, including Hugues De The and Ali Bazarbachi. Their collaboration has enriched her research and provided valuable insights into the complexities of leukemia treatment.

Conclusion

Hiba El Hajj is a trailblazer in the field of cancer research, with her innovative patent offering new hope for patients suffering from acute myeloid leukemia. Her dedication to advancing medical science is evident through her work and collaborations.